Aneon Brillient, LLC

Reston, VA Doing business as Aneon Brillient LLC Part of Aneon Federal Solutions LLC

UEI
MS8HMAY331Q5
CAGE
9CUL5
Primary NAICS
541611 Administrative Management and General Management Consulting Services
SAM.gov registration
Active through

Company facts

SBA certifications
8(a) Joint Venture
– · Ended
Self-certified in SAM.gov
  • Minority Owned Business
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Asian-Pacific American Owned
  • Small Business Joint Venture
  • Limited Liability Company
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
Show all
Corporate family
SAM.gov registration date
Physical address
1893 Metro Center Dr #210, Reston, VA 20190, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

About Aneon Brillient, LLC

Aneon Brillient, LLC, an SBA-certified 8(a) joint venture minority-owned, small disadvantaged business based in Reston, Virginia, operates exclusively as a prime contractor delivering professional services to the federal government, with customer concentration heavily weighted toward the Food and Drug Administration. The company is a child entity of Aneon Federal Solutions LLC, also an SBA 8(a) program participant.

Aneon Brillient's capability portfolio centers on FDA-specialized professional services: medical and scientific writing, administrative staffing, quality assurance, database administration, FOIA support, and regulatory scientific support. Recent work includes a $1.9 million 8(a) sole source labor-hour contract awarded in August 2026 supporting the FDA's Oncology Center of Excellence through August 2027, a $4.2 million labor-hour engagement for Center for Drug Evaluation and Research supply chain technical support services through June 2028, a $3.3 million CDER professional services contract awarded August 2024, and a $2.1 million four-year medical and scientific writing contract for CDER running through August 2028. The company has also secured smaller task orders for communications support, database administration, webmaster services, quality management, IT professional services, and transcription support across multiple FDA centers including CDER, Center for Biologics Evaluation and Research, Center for Devices and Radiological Health, and the Office of Policy, Legislation and International Affairs.

Customer concentration is extreme: the FDA accounts for 23 of 24 awards and the full $29.3 million in combined potential value from the source data window (February 2024 through August 2026). The single non-FDA award is Aneon Brillient's seat on the GSA OASIS+ 8(a) multiple-award IDIQ, which carries a multi-billion-dollar ceiling and was awarded April 16, 2025, with performance through April 15, 2030. This vehicle theoretically positions the vendor to pursue task orders across federal agencies, though no task order activity against OASIS+ 8(a) appears in the source data to date.

Award activity has declined sharply: 18 awards in 2024, 5 in 2025, and 1 in 2026 (year-to-date through mid-August). Eleven awards representing $18.1 million in combined potential value have ultimate completion dates within the next twenty-four months, creating recompete exposure concentrated in FDA programs. The company's 8(a) certification expires August 7, 2026, which will materially alter its competitive posture in federal contracting.

SCI-reported invoiced revenue totaled $3.5 million in FY2024 across 15.0 FTEs delivered to federal customers on service contracts above the $150,000 reporting threshold. Government-paid hourly rates ranged from $77.89 per hour (10th percentile) to $151.61 per hour (90th percentile), with a median rate of $111.74 per hour. Aneon Brillient performs all reported labor internally; the source data shows zero percent subcontractor engagement across SCI-reportable prime contracts in FY2024, indicating the company builds its own delivery teams rather than relying on subcontracted support.

Aneon Brillient's contract strategy is heavily skewed toward 8(a) sole source awards; 19 of the 23 FDA contracts carry 8(a) sole source designations, while 4 carry direct 8(a) awards with no set-aside used. This posture is characteristic of the 8(a) program participation profile and constrains the vendor to set-aside competition. The absence of competitive 8(a) or full-and-open FDA work in the source data suggests the company has not faced headwind in sole source settings with its primary customer.

Contract vehicles

Quick answers

What is Aneon Brillient, LLC's UEI?

Aneon Brillient, LLC's Unique Entity ID (UEI) in SAM.gov is MS8HMAY331Q5.

What is Aneon Brillient, LLC's CAGE code?

Aneon Brillient, LLC's CAGE code is 9CUL5.

What is Aneon Brillient, LLC's primary NAICS code?

Aneon Brillient, LLC's primary NAICS code is 541611 (Administrative Management and General Management Consulting Services).

Where is Aneon Brillient, LLC located?

Aneon Brillient, LLC's physical address in SAM.gov is 1893 Metro Center Dr #210, Reston, VA 20190, USA.

Is Aneon Brillient, LLC registered in SAM.gov?

Yes. Aneon Brillient, LLC's SAM.gov registration is active through December 5, 2026.

Who is Aneon Brillient, LLC's parent company?

Aneon Brillient, LLC is part of Aneon Federal Solutions LLC.

Which contract vehicles does Aneon Brillient, LLC hold?

Aneon Brillient, LLC holds a place on 1 federal contract vehicle: OASIS+8A.

What is Aneon Brillient, LLC's most recent federal award?

Aneon Brillient, LLC's most recent federal contract award is Direct 8(a) award, stand-alone, labor-hour (LH) type contract for food and drug administration for oncology center of… (75F40126C00027), from Food and Drug Administration, on August 12, 2026.

On GovTribe

See Aneon Brillient, LLC's full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors